Results 151 to 160 of about 57,220 (227)

QSAR Regression Models for Predicting HMG-CoA Reductase Inhibition. [PDF]

Pharmaceuticals (Basel)
Ancuceanu R, Popovici PC, Drăgănescu D, Busnatu Ș, Lascu BE, Dinu M.   +5 more
europepmc   +1 more source

HMG-CoA Reductase Inhibitors (Statins) May Preserve Hepatic Function and Reduce Portal-Systemic Shunting in Compensated Advanced Chronic Liver Disease: Results From the SHUNT-V Study. [PDF]

Clin Transl Gastroenterol
Rahimi RS, Mena E, Lucas KJ, McRae MP, Kittelson J, Imperial JC, Smith AD, Everson GT, SHUNT-V Subjects, Investigators, and Coordinators.   +10 more
europepmc   +1 more source

Computer-aided, resistance gene-guided genome mining for proteasome and HMG-CoA reductase inhibitors. [PDF]

J Ind Microbiol Biotechnol, 2023
Jenkinson CB, Podgorny AR, Zhong C, Oakley BR.   +3 more
europepmc   +1 more source

Effects of HMG CoA reductase (HMGCR) deficiency on skeletal muscle development. [PDF]

FEBS J
Gunasekaran M, Littel HR, Wells NM, Turner J, Campos G, Venigalla S, Estrella EA, Ghosh PS, Daugherty AL, Stafki SA, Kunkel LM, Foley AR, Donkervoort S, Bönnemann CG, Toledo-Bravo de Laguna L, Nascimento A, Natera-de Benito D, Draper I, Bruels CC, Pacak CA, Kang PB.   +20 more
europepmc   +1 more source

In Silico Characterization of Withania coagulans Bioactive Compounds as Potential Inhibitors of Hydroxymethylglutaryl (HMG-CoA) Reductase of Mus musculus. [PDF]

ACS Omega, 2023
Azmi MB, Khan F, Asif U, Khurshid B, Wadood A, Qureshi SA, Ahmed SDH, Mudassir HA, Sheikh SI, Feroz N.   +9 more
europepmc   +1 more source

LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice [PDF]

, 2018
Jeong, Lak Shin, Jeong, Se-Jin, Kim, Gyudong, Oh, Goo Taeg, Park, Jong-Gil, Yu, Jinha   +5 more
core   +1 more source

Srebf and Runx3 regulate hepatic HMG-CoA reductase and intracellular cholesterol under hypoxia. [PDF]

Cell Mol Life Sci
Poovitha S, Khan AA, Arkat S, Vijayakumar A, Natarajan B, Barthwal MK, Mahapatra NR.   +6 more
europepmc   +1 more source

Statin activation of skeletal ryanodine receptors (RyR1) is a class effect but separable from HMG-CoA reductase inhibition. [PDF]

Br J Pharmacol, 2022
Lindsay C, Musgaard M, Russell AJ, Sitsapesan R.   +3 more
europepmc   +1 more source

Synthesis of Caged HMG-CoA Reductase Substrates for the Elucidation of Cellular Pathways. [PDF]

J Org Chem
O'Connell RJ, Dolphin NJ, Ferraudi G, Lee M, Stauffacher CV, Helquist P, Wiest O.   +6 more
europepmc   +1 more source

Lipid liquid-crystalline nanoparticles as a suitable platform for accommodating sensitive membrane proteins: monitoring the activity of HMG-CoA reductase. [PDF]

J Nanobiotechnology
Zaborowska-Mazurkiewicz M, Nazaruk E, Bilewicz R.   +2 more
europepmc   +1 more source